Coya Therapeutics’ $15.25 Million Initial Public Offering

Laura Testa
Tagged:

Lowenstein Sandler represented Coya Therapeutics in the transaction.Coya Therapeutics, Inc. (Nasdaq: COYA), a clinical-stage biotechnology company developing proprietary therapies to enhance the function of regulatory T…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

…

This content is for Standard 1 Year members only.
Login Join Now